The Effect of Early Attainment of Minimal Disease Activity on Radiographic Outcomes: A Real-World Longitudinal Cohort Study in Psoriatic Arthritis.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 40374510.
- Also identified by DOI 10.3899/jrheum.2024-1162.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To evaluate the effect of achieving minimal disease activity (MDA) within the first year on radiologic damage at 3-year follow-up in patients with newly diagnosed psoriatic arthritis (PsA). Data were used from the Dutch southwest Early PsA cohort, a real-world cohort of newly diagnosed patients with PsA, focusing on those with oligoarthritis or polyarthritis. Patients were stratified into 3 groups: (1) sustained MDA, achieving MDA at least at both 9 and 12 months post diagnosis; (2) nonsustained MDA, achieving MDA in the first year but not sustaining it at 9 and 12 months; (3) no MDA, not achieving MDA in the first year. Radiographic assessment was used by the modified Total Sharp/van der Heijde score for PsA. Group comparisons at 3-year follow-up for radiographic changes were conducted using a linear mixed model. Two hundred eighty-four patients were categorized into 3 groups: 96 patients (34%) in the sustained MDA group, 83 (29%) in the nonsustained MDA group, and 105 (37%) in the no-MDA group. According to baseline characteristics, in the no-MDA group, a notably higher rate of female individuals (70%) and an elevated tender joint count (median 7, IQR 4-12) were observed. Patients who did not achieve MDA in the first year experienced remarkably higher radiographic changes during follow-up than the sustained MDA group (β 0.05, 95% CI 0.02-0.08, <i>P</i> < 0.01). Radiographic changes during the 3-year follow-up were markedly higher in those unable to achieve MDA within the first year of follow-up, emphasizing the long-term structural benefits of reaching stringent disease activity targets early in the disease course.
Medical subject headings
- Arthritis, Psoriatic
- Antirheumatic Agents